All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @mx.gialu on TikTok · 20s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @mx.gialu's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00Remember with you at a lot of days
  2. 0:02Let's say it's up, we'll take, triple take
  3. 0:05Turn it on, make it twist up, back at your place
  4. 0:08Baby baby, mmm, I'm not taking enough time
  5. 0:12Oh, any you guess

@mx.gialu's testosterone journey claims, fact-checked

Gialu

TikTok creator

466.2K viewsWatch on TikTok

Quick answer

The caption describes a nonbinary individual's first year on gender-affirming testosterone therapy, characterized by concurrent body dysmorphia and gender euphoria during early low-dose treatment, followed by six months at a higher maintenance dose. These experiences align with documented patterns in the clinical literature on transmasculine hormone therapy, including body composition changes and mixed psychological responses during dose titration. No specific dose, formulation, or clinical protocol is described, and the video should not be used as a guide for self-managed hormone therapy.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

TRT social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 7 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For @mx.gialu's testosterone journey claims, fact-checked, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

@mx.gialu's testosterone journey claims, fact-checked is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.

Claim path

Keep researching this testosterone and trt video claims cluster

Best for searchers turning TRT social claims into a safer lab-backed provider discussion.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "@mx.gialu's testosterone journey claims, fact-checked" from Gialu. We read the clip as a TRT social video fact-checks claim about Testosterone, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: The caption describes a nonbinary individual's first year on gender-affirming testosterone therapy, characterized by concurrent body dysmorphia and gender euphoria during early low-dose treatment, followed by six months at a higher maintenance dose.

The reason this review is not generic is the source wording and the canonical claim label "trt testosterone especially the first year was hard as i stru." In this clip, the useful excerpt is: "Remember with you at a lot of days Let's say it's up, we'll take, triple take Turn it on, make it twist up, back at your place Baby baby, mmm, I'm not taking enough time Oh, any you guess" That wording changes the review because it points to Testosterone evidence, safety, and patient-fit context, not a one-size-fits-all protocol.

The source trail for this page is checked against Cardiovascular Safety of Testosterone-Replacement Therapy (2023), Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline (2010), and Functional testosterone deficiency in aging men: Clinical impact, diagnostic pathways, and treatment strategies (2026), plus the creator's own wording. Testosterone decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

Gender euphoria and body dysmorphia can coexist during hormone therapy.
People who land here are usually comparing the Testosterone claim with [object Object].
The strongest next step is to compare the claim with FormBlends' Testosterone guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

The caption describes a nonbinary individual's first year on gender-affirming testosterone therapy, characterized by concurrent body dysmorphia and gender euphoria during early low-dose treatment, followed by six months at a higher maintenance dose.

FormBlends verdict

Testosterone evidence, safety, and patient-fit context

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • The caption describes a nonbinary individual's first year on gender-affirming testosterone therapy, characterized by concurrent body dysmorphia and gender euphoria during early low-dose treatment, followed by six months at a higher maintenance dose. These experiences align with documented patterns in the clinical literature on transmasculine hormone therapy, including body composition changes and mixed psychological responses during dose titration. No specific dose, formulation, or clinical protocol is described, and the video should not be used as a guide for self-managed hormone therapy.
  • Klaver et al. (2019, JCEM) documented significant weight and lean mass increases in transmasculine individuals within two years of starting testosterone, making weight gain in the first year a clinically expected, not alarming, outcome.
  • Gender euphoria and body dysmorphia can coexist during hormone therapy. Van der Miesen et al. (2021) found psychological improvements from gender-affirming hormones do not automatically resolve all body image concerns.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • Klaver et al. (2019, JCEM) documented significant weight and lean mass increases in transmasculine individuals within two years of starting testosterone, making weight gain in the first year a clinically expected, not alarming, outcome.
  • Gender euphoria and body dysmorphia can coexist during hormone therapy. Van der Miesen et al. (2021) found psychological improvements from gender-affirming hormones do not automatically resolve all body image concerns.
  • Turban et al. (2022, JAMA Network Open) found gender-affirming care significantly reduces suicidality and psychological distress, but concurrent mental health support remains an important part of care.
  • Low-dose initiation followed by titration is standard clinical practice per Endocrine Society guidelines. There is no universal "full dose" of testosterone, appropriate levels depend on individual labs and clinical goals.
  • Testosterone therapy requires ongoing lab monitoring including hematocrit, lipid panels, liver function, and serum hormone levels. This was not mentioned in the video and represents a gap in information for viewers.
  • Formulation matters: testosterone cypionate, enanthate, gels, and patches produce different pharmacokinetic profiles and require different monitoring schedules. Personal experience on one formulation does not transfer directly to another.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @mx.gialu actually say?

Honestly? Not much that's medically specific, and that's worth acknowledging upfront. The transcript captured in this video appears to be song lyrics or background audio rather than coherent medical claims. What we do have is the caption, where @mx.gialu shares that their first year on testosterone was hard, that they struggled with body dysmorphia while gaining weight, that they simultaneously felt gender euphoria, and that they started on a low dose before moving to what they call the "full" dose for the past six months.

Those are personal experience claims, not clinical ones. There's a meaningful difference. The creator isn't telling you what to do or dose. They're describing their own experience. That matters when we're evaluating what, if anything, needs correcting.

Does the science back this up?

The experiences described, weight changes during the first year of testosterone therapy and the coexistence of body dysmorphia alongside gender euphoria, are both documented in the clinical literature. This isn't just anecdote.

A 2021 study by van der Miesen et al. published in Psychological Medicine found that gender-affirming hormone therapy was associated with significant reductions in gender dysphoria and improvements in psychological wellbeing, but body image concerns didn't always resolve alongside gender euphoria. The two can genuinely coexist, which is what this creator describes.

On weight: testosterone therapy in transmasculine and nonbinary individuals is associated with increases in lean muscle mass and, in some cases, overall body weight. A 2019 study by Klaver et al. in The Journal of Clinical Endocrinology and Metabolism tracked body composition changes in transgender men over two years and found significant increases in body weight and fat-free mass. Early gains can feel disorienting when someone is also processing body image concerns.

So the broad strokes here check out.

What did they get wrong (or right)?

The creator got the emotional reality right. The tension between experiencing gender euphoria and struggling with body dysmorphia during testosterone therapy is clinically recognized, not a contradiction. Research consistently shows that hormone therapy improves gender-related distress while body image concerns, particularly those unrelated to gender dysphoria, may persist or even shift in new directions as the body changes.

The reference to a "full" dose is vague enough that it's not medically problematic. They aren't recommending a dose. They're describing a personal escalation from low to higher dosing under what we'd assume is clinical supervision. We have no reason to assume otherwise, and we're not going to fill in gaps with negative assumptions.

What's missing is any mention of monitoring. Testosterone therapy requires regular bloodwork, including hematocrit, liver function, lipid panels, and hormone levels. The absence of that context in a 466K-view video is worth flagging, not as a criticism of the creator, but as context viewers deserve.

What should you actually know?

If you're considering testosterone therapy, whether for gender-affirming purposes or hormonal optimization, here's what the research actually supports:

  • Body composition changes, including weight gain, are common in the first one to two years. Klaver et al. (2019) documented this clearly. It's not a sign something is wrong.
  • Gender euphoria and body dysmorphia can coexist. A 2022 review by Turban et al. in JAMA Network Open confirmed that gender-affirming care reduces suicidality and distress, but concurrent mental health support remains important.
  • Starting at a low dose is a clinically common approach. Dose titration should be managed by a licensed provider based on bloodwork, not social media timelines.
  • "Full dose" is not a standard clinical term. Appropriate testosterone levels vary by individual, by formulation (cypionate, enanthate, gel, patch), and by clinical goals. Anyone telling you there's a universal "full dose" is oversimplifying.

The creator's experience is valid. It's also one data point. Your physiology, your mental health history, and your clinical needs are different. Work with a provider who runs labs, not just vibes.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Gialu · TikTok creator

466.2K views on this video

Testosterone ✨️ especially the first year was hard as I struggled with body dysmorphia as a I gained weight and at the same time I felt so much gender euphoria - i started with a low dose but out of s

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about klaver et al. (2019, jcem) documented significant weight?

Klaver et al. (2019, JCEM) documented significant weight and lean mass increases in transmasculine individuals within two years of starting testosterone, making weight gain in the first year a clinically expected, not alarming, outcome.

What does the video say about gender euphoria?

Gender euphoria and body dysmorphia can coexist during hormone therapy. Van der Miesen et al. (2021) found psychological improvements from gender-affirming hormones do not automatically resolve all body image concerns.

What does the video say about turban et al. (2022, jama network open) found gender-affirming care?

Turban et al. (2022, JAMA Network Open) found gender-affirming care significantly reduces suicidality and psychological distress, but concurrent mental health support remains an important part of care.

What does the video say about low-dose initiation followed by titration?

Low-dose initiation followed by titration is standard clinical practice per Endocrine Society guidelines. There is no universal "full dose" of testosterone, appropriate levels depend on individual labs and clinical goals.

What does the video say about testosterone therapy requires ongoing lab monitoring including hematocrit, lipid panels,?

Testosterone therapy requires ongoing lab monitoring including hematocrit, lipid panels, liver function, and serum hormone levels. This was not mentioned in the video and represents a gap in information for viewers.

What does the video say about formulation matters: testosterone cypionate, enanthate, gels,?

Formulation matters: testosterone cypionate, enanthate, gels, and patches produce different pharmacokinetic profiles and require different monitoring schedules. Personal experience on one formulation does not transfer directly to another.

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Not medical advice. This video was made by Gialu, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.